Babak joined Pfizer in 2008, leading the marketing effort for several brands at different stages in their life cycle which includes the re-launch of Fragmin in Europe; the worldwide launch of Elelyso in the rare disease space; the Hospital Generics portfolio strategy in the Emerging Markets; and more recently Lipitor after the loss of exclusivity.
Save the Children’s Senegal office opened in October 2012, with operations in West and Central Africa, with 10 countries and 10 individual strategies. In 2014-2015, Save the Children would like to bring the countries within this region under one strategic framework, building on the strengths of the region, while ensuring they are investing in relevant areas of new programming. Babak will serve with local staff to start this strategic review and planning.
During his fellowship, Babak hopes to gain deeper experience of issues in the emerging markets and the strategies adopted to manage them in resource restrained environments. This learning will apply to implementing effective global marketing strategies when he returns to Pfizer.
Since moving to New York, Babak has been involved in many children’s charities ranging from teaching mathematics to blind students to running sports programs with children with special needs.
Save the Children is the leading independent organization creating lasting change in the lives of children in need in the United States and around the world. Recognized for their commitment to accountability, innovation and collaboration, their work takes them into the heart of communities where they help children and families help themselves.